OHBs, Billion

OHB's €1 Billion IRIS² Win Adds Fuel to a Growth Story Already Gathering Momentum

Published on 08/20/2026 at 13:22 | Redaktion boerse-global.de

OHB wins €1B IRIS² satellite deal, boosting backlog and validating growth; H1 2026 results show strong EBITDA growth, but analyst targets vary.

OHB Secures €1B IRIS² Satellite Contract, Stock Rebounds
OHB's €1 Billion IRIS² Win Adds Fuel to a Growth Story Already Gathering Momentum Illustration mit AI erstellt übermittelt durch boerse-global.de

The confirmation landed on Monday, and for OHB shareholders it was the validation they had been waiting for. The Bremen-based space company secured the contract for 18 satellites under Europe's IRIS² satellite network — a deal worth close to €1 billion, with the first spacecraft slated for launch in 2029. The news sent the stock sharply higher, a welcome reprieve after the shares had shed 7.7 percent since their SDAX index inclusion just over a week earlier.

That recent weakness, driven largely by index mechanics rather than operational setbacks, now looks increasingly like noise in the signal. The IRIS² award is the latest in a string of tangible milestones that suggest OHB's growth narrative has moved firmly from promise to execution.

A Half-Year Scorecard That Speaks Volumes

The satellite order lands on top of a set of first-half 2026 results that were already turning heads. Total output climbed 11 percent to €627.9 million, while adjusted EBITDA rose 31 percent to €60.4 million and adjusted EBIT improved an even more striking 46 percent to €38.9 million. The order backlog swelled to €3.304 billion, with the lion's share — €2.566 billion — sitting in the Space Systems division, precisely where the new IRIS² contract will be booked.

Management had flagged during the earnings call that IRIS², alongside the Sentinel constellation, ClearSpace-1 and other projects, would be a key driver for the second half. That guidance has now been backed by hard contracts. The company also reaffirmed its full-year outlook: roughly €1.4 billion in total output and an adjusted EBITDA margin between 10.5 and 11 percent.

The backlog story gains further depth when measured against the year-ago figure of €3.067 billion. Management notes that order intake remains dynamic and is expected to peak only in the second half — suggesting the current numbers may understate what's coming.

Should investors sell immediately? Or is it worth buying OHB SE?

Analyst Divergence Reflects Valuation Uncertainty

The analyst community has responded with a spread of opinions that underscores just how unsettled the debate over OHB's fair value remains. Deutsche Bank initiated coverage on Friday with a Buy rating and a €275 price target, joining Jefferies, which reaffirmed its Buy and €280 target after reviewing the second-quarter numbers. Berenberg sits at the more bullish end with €358, while Goldman Sachs has taken a more cautious stance with a neutral rating and €250 target.

Both the Deutsche Bank and Jefferies targets sit comfortably above Thursday's closing price of €240.50, signaling that at least part of the Street views the recent pullback as an entry point rather than an exit signal. The stock currently trades roughly 16 percent below its 50-day moving average of €285.12 — a technical indicator that the recent slide has dented short-term momentum, even if the fundamental picture tells a different story.

A Fortified Balance Sheet, With Dilution as the Trade-Off

The July capital increase, which raised gross proceeds of around €510 million, has fundamentally reshaped OHB's financial profile. The equity ratio jumped from 27.5 percent at the end of 2025 to 43.3 percent by mid-year — a transformation that gives management the firepower to pursue large contracts without straining the balance sheet. The secondary source puts the raise at €484 million, reflecting the net figure after costs.

That financial flexibility comes at a price for existing shareholders: dilution. The Fuchs family, holding more than 60 percent, and KKR, with roughly 20 percent, continue to dominate the ownership structure, but the expanded share count is a factor investors must weigh.

Patience Required on the Next Catalysts

Not everything is moving in the right direction at the same speed. The debut flight of Rocket Factory Augsburg has been postponed once again, this time due to tank issues. And management has indicated that major German defense contracts — a potentially significant growth driver — are not expected until 2027 at the earliest. For those hoping for immediate additional catalysts, the message is clear: the runway is longer than some might like.

The next milestone on the calendar is the third-quarter report, scheduled for November 6. Between now and then, the market will have time to digest whether the recent analyst endorsements — now spanning Deutsche Bank, Jefferies and Berenberg on the bullish side — represent the beginning of a broader consensus shift or merely isolated votes of confidence in a story that still has plenty to prove.

Ad

OHB SE Stock: New Analysis - 20 August

Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated OHB SE analysis...

Disclaimer...

en | DE0005936124 | OHBS | boerse | 69975616 |